Cargando…

Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239

Detalles Bibliográficos
Autores principales:	Daitch, Vered, Paul, Mical, Leibovici, Leonard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739034/ https://www.ncbi.nlm.nih.gov/pubmed/36498604 http://dx.doi.org/10.3390/jcm11237029

Ejemplares similares

Reply to Daitch et al. Comment on “Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239”
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019)

Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates
por: Kon, Hadas, et al.
Publicado: (2021)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii
por: Kon, Hadas, et al.
Publicado: (2023)

Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
por: Lee, Ji-Young, et al.
Publicado: (2017)

The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit
por: Ceccarelli, Giancarlo, et al.
Publicado: (2015)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2021)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Park, Jae-Min, et al.
Publicado: (2021)

Efficacy of Intravenous Colistin Monotherapy Versus Colistin Combined With Meropenem in Patients With Multidrug-Resistant Infections: A Retrospective Observational Study
por: Baig, Mehwish, et al.
Publicado: (2023)

Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection
por: Katip, Wasan, et al.
Publicado: (2022)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant Acinetobacter baumannii Infections: A Preliminary Study
por: Sirijatuphat, Rujipas, et al.
Publicado: (2022)

Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii
por: Choi, Hee Kyoung, et al.
Publicado: (2014)

Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Ayerbe-Algaba, Rafael, et al.
Publicado: (2018)

In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii
por: Percin, Duygu, et al.
Publicado: (2014)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients: A Propensity Score-Matched Analysis
por: Katip, Wasan, et al.
Publicado: (2020)

Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii
por: Nordqvist, H., et al.
Publicado: (2016)

Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination
por: Sato, Yoshinori, et al.
Publicado: (2021)

Effect of combined colistin and meropenem against meropenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa by checkerboard method: A cross sectional analytical study
por: Gunalan, Anitha, et al.
Publicado: (2021)

The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii: a randomized controlled clinical trial
por: Momenzadeh, Mahnaz, et al.
Publicado: (2022)

Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection
por: Chen, Zhijin, et al.
Publicado: (2015)

Curcumin alleviates persistence of Acinetobacter baumannii against colistin
por: Kaur, Amanjot, et al.
Publicado: (2018)

Two types of colistin heteroresistance in Acinetobacter baumannii isolates
por: Hong, Yoon-Kyoung, et al.
Publicado: (2020)

New Mutations Involved in Colistin Resistance in Acinetobacter baumannii
por: Sun, Bingbing, et al.
Publicado: (2020)

Colistin Treatment Affects Lipid Composition of Acinetobacter baumannii
por: Tao, Ye, et al.
Publicado: (2021)

Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
por: Novović, Katarina, et al.
Publicado: (2023)

PYED-1 Overcomes Colistin Resistance in Acinetobacter baumannii
por: Stabile, Maria, et al.
Publicado: (2023)

Evaluation of the synergistic effect of a combination of colistin and tigecycline against multidrug-resistant Acinetobacter baumannii
por: Kaya, Ilkem Acar, et al.
Publicado: (2017)

Colistin potentiation in multidrug-resistant Acinetobacter baumannii by a non-cytotoxic guanidine derivative of silver
por: Kumar, Deepak, et al.
Publicado: (2023)

Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment
por: Park, Yu Jin, et al.
Publicado: (2018)

1542. The Evaluation of the In Vitro Synergy of Colistin in Combination with Meropenem and Tigecycline against 50 Multi-Drug-resistant Acinetobacter baumannii strains
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran
por: Vakili, Bahareh, et al.
Publicado: (2014)

Post Neurosurgical Meningitis due to Colistin Heteroresistant Acinetobacter baumannii
por: Moosavian, Mojtaba, et al.
Publicado: (2014)

The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii
por: Mu, Xinli, et al.
Publicado: (2016)

Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii
por: Da Silva, Gabriela Jorge, et al.
Publicado: (2017)

Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii
por: Boinett, Christine J., et al.
Publicado: (2019)

The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii
por: Seleim, Shaimaa Mohamed, et al.
Publicado: (2022)

Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii
por: Kabic, Jovana, et al.
Publicado: (2022)

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods
por: Rodjun, Vipavee, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dui8oic4fsudqrl0ich5kd05qn